Literature DB >> 29727913

Variation in hyperemesis gravidarum definition and outcome reporting in randomised clinical trials: a systematic review.

M H Koot1,2, R C Boelig3, J Van't Hooft1,4, J Limpens5, T J Roseboom1,2, R C Painter1, I J Grooten1,2,6.   

Abstract

BACKGROUND: Hyperemesis gravidarum (HG) is a common cause of hospital admission in early pregnancy. There is no international consensus on the definition of HG, or on outcomes that should be reported in trials. Consistency in definition and outcome reporting is important for the interpretation and synthesis of data in meta-analyses.
OBJECTIVE: To identify which HG definitions and outcomes are currently in use in trials. SEARCH STRATEGY: We searched the following sources: (1) Cochrane Central Register of Controlled Trials, (2) Embase and (3) Medline for published trials and the WHO-ICTRP database for ongoing trials (27 October 2017). SELECTION CRITERIA: All randomised clinical trials reporting on any intervention for HG were eligible. DATA COLLECTION AND ANALYSIS: Two reviewers independently assessed trial eligibility and extracted data on HG definition and outcomes. MAIN
RESULTS: We included 31 published trials reporting data from 2511 women and three ongoing trials with a planned sample size of 360 participants. We identified 11 definition items. Most commonly used definition items were vomiting (34 trials) and nausea (30 trials). We identified 34 distinct outcomes. Most commonly reported outcomes were vomiting (29 trials), nausea (26 trials), need for hospital treatment (14 trials) and duration of hospital (re)admission(s) (14 trials).
CONCLUSION: There is substantial variation of HG definition and outcome reporting in trials. This hampers meaningful aggregation of trial results in meta-analysis and implementation of evidence in guidelines. To overcome this, international consensus on a definition and a core outcome set for HG trials should be developed. TWEETABLE ABSTRACT: There is a wide variation of definitions and outcomes reported in trials on hyperemesis gravidarum.
© 2018 Royal College of Obstetricians and Gynaecologists.

Entities:  

Keywords:  Core outcome sets; definition; hyperemesis gravidarum; outcomes; systematic review

Mesh:

Year:  2018        PMID: 29727913     DOI: 10.1111/1471-0528.15272

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  8 in total

Review 1.  Hyperemesis gravidarum induced refeeding syndrome causes blood cell destruction: a case report and literature review.

Authors:  Xiyu Pan; Ran Chu; Jinyu Meng; Qiannan Wang; Yue Zhang; Kun Song; Xingsheng Yang; Beihua Kong
Journal:  BMC Pregnancy Childbirth       Date:  2021-05-09       Impact factor: 3.007

2.  Rating of four different foods in women with hyperemesis gravidarum: a randomised controlled trial.

Authors:  Gi Ni Tan; Peng Chiong Tan; Jesrine Gek Shan Hong; Balaraman Kartik; Siti Zawiah Omar
Journal:  BMJ Open       Date:  2021-05-13       Impact factor: 2.692

3.  Hyperparathyroidism presenting as hyperemesis and acute pancreatitis in pregnancy: A case report.

Authors:  Wen-Hsuan Tsai; Chun-Chuan Lee; Shih-Ping Cheng; Yi-Hong Zeng
Journal:  Medicine (Baltimore)       Date:  2021-04-09       Impact factor: 1.817

Review 4.  Managing hepatic complications of pregnancy: practical strategies for clinicians.

Authors:  Maura Alice Morrison; Yooyun Chung; Michael A Heneghan
Journal:  BMJ Open Gastroenterol       Date:  2022-03

5.  Readmissions due to hyperemesis gravidarum: a nation-wide Finnish register study.

Authors:  Miina Nurmi; Päivi Rautava; Mika Gissler; Tero Vahlberg; Päivi Polo-Kantola
Journal:  Arch Gynecol Obstet       Date:  2022-02-28       Impact factor: 2.493

6.  Development of a core outcome set for studies on prevention and management of pregnancy-associated venous thromboembolism (COSPVenTE): a study protocol.

Authors:  Alexandria King; Rohan D'Souza; Lizabeth Teshler; Nadine Shehata; Ann K Malinowski
Journal:  BMJ Open       Date:  2020-07-19       Impact factor: 2.692

7.  Validating the effect of Ondansetron and Mirtazapine In Treating hyperemesis gravidarum (VOMIT): protocol for a randomised placebo-controlled trial.

Authors:  Anne Ostenfeld; Tonny Studsgaard Petersen; Tina Bergmann Futtrup; Jon Trærup Andersen; Andreas Kryger Jensen; Hanne Brix Westergaard; Lars Henning Pedersen; Ellen Christine Leth Løkkegaard
Journal:  BMJ Open       Date:  2020-03-24       Impact factor: 2.692

Review 8.  Effectiveness of Acupuncture in the Treatment of Hyperemesis Gravidarum: A Systematic Review and Meta-Analysis.

Authors:  Haizhen Lu; Chengwen Zheng; Yanmei Zhong; Linhao Cheng; Yi Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-27       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.